c-Kit Point mutation in patients with myeloproliferative disorders

References

• Besmer P., Murphy J. E., George P. C., Qiu F., Bergold P. J., Lederman L., Snyder H. W., Brodeur D, Jr., Zuckerman E. E., Hardy W. D. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (London) 1986; 320: 415–421
   PubMed Web of Science ®Google Scholar
• Yarden Y., Kuang W. J., Yang-Feng T., Coussens L., Munemitsu S., Dull T. J., Chen E., Schldessinger J., Francke U., Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for unidentified ligand. EMBO. J. 1987; 6: 3341–3351
   PubMed Web of Science ®Google Scholar
• Qiu F., Ray P., Brown K., Barker P. E., Jhanwar S., Ruddle F. H., Besmer P. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogene activation of v-kit involves deletion of extracellular domain and C terminus. EMBO. J. 1988; 7: 1003–1011
   PubMed Web of Science ®Google Scholar
• Duronio V., Welham M. J., Abraham S., Dryden P., Schrader J. W. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc. Natl. Acad. Sci. USA 1992; 89: 1581–1591
   Google Scholar
• Ikeda H., Kanakura Y., Tamaki T., Kuriu A., Kitayama H., Ishikawa J., Kanayama Y., Yonezawa T., Tariu S., Griffin J. D. Expression and functional role of the protooncogene c-kit in acute myeloblastic leukemia cells. Blood 1991; 78: 2962–2968
   PubMed Web of Science ®Google Scholar
• Goselink H. M., Williams D. E., Fibbe W. E., Wessels H. W., Beverstock G. C. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells. Blood 1992; 80: 750–757
   PubMed Web of Science ®Google Scholar
• Kubota A., Okamura S., Shimoda K., Harada M., Niho Y. The c-kit molecule and the surface immunophenotype of human acute leukemia. Leuk. Lymphoma 1994; 14: 421–428
   PubMed Web of Science ®Google Scholar
• Smith F. O., Broudy V. C., Zsebo K. M., Lampkin B. C., Buckley C. V., Buckley J. D., Opie T., Woods W. G., Hammond G. D., Bernstein I. D. Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the childrens cancer group. Blood 1994; 84: 847–852
   PubMed Web of Science ®Google Scholar
• Crosier P. S., Ricciardi S. T., Hall L. R., Vitas M. R., Clark S. C., Crosier K. E. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 1993; 82: 1151–1158
   PubMed Web of Science ®Google Scholar
• Caceres C. J., Rajotte D., Dumouchel J., Haddad P., Hoang T. Product of the steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor. J. Biol. Chem. 1994; 22: 12084–12091
   Google Scholar
• Lemoli R. M., Fogli M., Fortuna A., Amabile M., Zucchini P., Grande A., Martinelli G., Visani G., Ferrari S., Tura S. Interleukin-11 (IL-11) acts as synergistic factor for the proliferation of human myeloid leukaemic cells. Br. J. Haematol. 1995; 91: 319–326
   PubMed Web of Science ®Google Scholar
• Jaeobsen F. W., Dubois C. M., Rusten L. S., Veiby O. P., Jacobsen S. E. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression. J. Immunol. 1995; 154: 3732–3741
   PubMed Web of Science ®Google Scholar
• Hu Q., Trevisan M., Xu Y., Dong W., Berger S. A., Lyman S. D., Minden M. D. c-kit expression enhances the leukemogenic potential of 32D cells. J. Clin. Invest. 1995; 95: 2530–2508
   PubMed Web of Science ®Google Scholar
• Heinrich M. C., Dooley D. C., Keeble W. W. Transforming growth factor beta 1 inhibits expression of the gene product for steel factor and its receptors (c-kit). Blood 1995; 85: 1769–1780
   PubMed Web of Science ®Google Scholar
• Ridge S. A., Worwood M., Oscler D., Jacobs A., Padua A. R.A. FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc. Natl. Acad. Sci. USA 1990; 87: 1377–1380
   PubMed Web of Science ®Google Scholar
• Golub T. R., Barker G. F., Lovett M., Gilliland D. G. Fusion of platelet-derived growth factor receptor B to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5; 12) chromosomal translocation. Cell 1994; 77: 307–315
   PubMed Web of Science ®Google Scholar
• Furitsu T., Tsujimura T., Tono T., Ikeda H., Kitayama H., Koshimizu U., Sugahara H., Butterfield J. H., Ashman L. H., Kanayama Y., Matsuzawa Y., Kitamura Y., Kanakura Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J. Clin. Invest. 1993; 92: 1732–1744
   Google Scholar
• Nagata H., Worobec A. S., Oh C. K., Chowdhury B. A., Tannenbaum S., Suzuki Y., Metcalfe D. D. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. USA 1995; 92: 10560–10564
   PubMed Web of Science ®Google Scholar
• Arland M., Fiedler W., Samalecos A., Hossfeld D. K. Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML). Leukemia 1994; 8: 498–501
   PubMed Web of Science ®Google Scholar
• Kawaishi K., Kimura A., Katoh O., Sasaki A., Oguma N., Ihara A., Satow Y. Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukemia. Br. J. Haematol. 1996; 93: 367–374
   PubMed Web of Science ®Google Scholar
• Siitone T., Savolainen E. R., Koistinen P. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia 1994; 8: 631–637
   PubMed Web of Science ®Google Scholar
• Wognum A. W., Cornelissen J. J., Frassoni F., Ploemacher R. E., Lowenberg B., Wagemaker G. Diminished binding of kit ligand to immature hemopoietic cells in patients with chronic myeloid leukemia. Blood 1995; 86: 706, a
   Google Scholar
• Eaves C. J., Eaves A. C. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood 1978; 52: 1196–1201
   PubMed Web of Science ®Google Scholar
• Prchal J. F., Axelrad A. A. Bone-marrow responses in polycythemia vera. N. Engl. J. Med. 1974; 290: 1382
   PubMed Web of Science ®Google Scholar
• Juvonen E., Partanen S., Ruutu T. Colony formation by megakaryocytic progenitors in essential thrombocythaemia. Br. J. Haematol. 1987; 66: 161–164
   PubMed Web of Science ®Google Scholar
• Dai C. H., Krantz S. B., Green W. F., Gilbert H. S. Comparative analysis of response to stem cell factor (SCF) and c-kit receptor expression by purified normal and polycythemia vera (PV) blood BFU-E. Blood 1992; 80: 12a
   Google Scholar
• Nakata Y., Kimura A., Katoh O., Kawaishi K., Hyodo H., Abe K., Kuramoto A., Satow Y. c-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br. J. Haematol. 1995; 21: 661–663
   Web of Science ®Google Scholar
• McLaughlin J., Chianese E., Witte O. In vitro transformation of immature hematopoietic cells by the P210 bcr/abl oncogene product of the philadelphia chromosome. Proc. Natl. Acad. Sci. USA 1987; 84: 6558–6562
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia by the P210 bcrlabl gene of the philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Lev S., Blechman J., Nishikawa S.-I., Givol D., Yarden Y. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor. Mol. Cell. Biol. 1993; 13: 2224–2234
   PubMed Web of Science ®Google Scholar
• Lev S., Yarden Y., Givol D. Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J. Biol. Chem. 1992; 267: 15970–15977
   PubMed Web of Science ®Google Scholar
• Cantley L. C., Auger K. R., Carpenter C., Duckworth B., Graziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell 1990; 64: 281–302
   Web of Science ®Google Scholar